|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 5/097 | (2006.01) |
| C07K 5/062 | (2006.01) | ||
| C07K 5/083 | (2006.01) | ||
| A61K 38/21 | (2006.01) | ||
| C07K 5/08 | (2006.01) |
| (11) | Number of the document | 2618831 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11827336.6 |
| Date of filing the European patent application | 2011-09-20 | |
| (97) | Date of publication of the European application | 2013-07-31 |
| (45) | Date of publication and mention of the grant of the patent | 2016-01-06 |
| (46) | Date of publication of the claims translation | 2016-02-10 |
| (86) | Number | PCT/US2011/052304 |
| Date | 2011-09-20 |
| (87) | Number | WO 2012/040167 |
| Date | 2012-03-29 |
| (30) | Number | Date | Country code |
| 201161499994 P | 2011-06-22 | US | |
| 385058 P | 2010-09-21 | US | |
| 201161504616 P | 2011-07-05 | US |
| (72) |
OR, Yat Sun, US
MA, Jun, US
WANG, Guoqiang, US
LONG, Jiang, US
WANG, Bin, US
|
| (73) |
Enanta Pharmaceuticals, Inc.,
500 Arsenal Street, Watertown, MA 02472,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Makrocikliniai iš prolino gauti HCV serino proteazės inhibitoriai |
| MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-08-25 | 15 | 289.00 EUR |
| 2026-09-20 |